2122830-90-2
Chemical Structure
Flibanserin-d4
Synonym(s): BIMT-17-d4;BIMT-17BS-d4
- CAS No.: 2122830-90-2
- Formula:C20H17D4F3N4O
- Molecular Weight:394.43
IUPAC Name: 1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one-4,5,6,7-d4
InChIKey: PPRRDFIXUUSXRA-ZEJCXXMWSA-N
SMILES: O=C1NC2=C([2H])C([2H])=C([2H])C([2H])=C2N1CCN3CCN(C4=CC=CC(C(F)(F)F)=C4)CC3
Biological Activity: Flibanserin-d4 (BIMT-17-d4; BIMT-17BS-d4) is the d4-labeled Flibanserin (HY-A0095). Flibanserin is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research[1]-[5].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Flibanserin-d4 | Flibanserin-d4 (BIMT-17-d4; BIMT-17BS-d4) is the d4-labeled Flibanserin (HY-A0095). Flibanserin is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research-. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Flibanserin (Standard) | ≥98% | Flibanserin (Standard) is the analytical standard of Flibanserin. This product is intended for research and analytical applications. Flibanserin (BIMT-17; BIMT-17BS) is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research-. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Flibanserin-d4-1 | 99.28% | Flibanserin-d4-1 (BIMT-17-d4-1; BIMT-17BS-d4-1) is the d4-labeled Flibanserin (HY-A0095). Flibanserin is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research-. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Flibanserin | 99.9% | Flibanserin (BIMT-17; BIMT-17BS) is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research-. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Fayed M, et al. Insights into Flibanserin Oxidative Stress Degradation Pathway: In Silico – In Vitro Toxicity Assessment of Its Degradates[J]. New Journal of Chemistry, 2021.
- [5]. Gelman F, et al. Flibanserin for hypoactive sexual desire disorder: place in therapy. Ther Adv Chronic Dis. 2017 Jan;8(1):16-25. [Content Brief]
